Skip to main content
. 2020 Oct 7;12(1):1829334. doi: 10.1080/19420862.2020.1829334

Figure 3.

Figure 3.

Clearance of mAbs in naïve Tg32, naïve Tg32-hFc, immunized Tg32, IVIg-preloaded Tg32, and naïve Fcgrt KO mice. (a) Plasma concentration-time course and (b) β-phase half-lives of HuLys11. (c) Log-linear plasma concentration-time course and (d) β-phase half-lives of trastuzumab. Mean ± SEM of cohorts from (a). ND, Half-life of Fcgrt KO mice too low to be computed.